# The PORTuguese Registry of Supera Supported Femoral-Fopliteal Revascularization (SupPORT Registry)

Study · id `cardio:ct-nct06416644` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06416644](<https://clinicaltrials.gov/study/NCT06416644>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06416644

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT06416644. Allocation not applicable; no masking; primary purpose treatment. Start 2023-04-01 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT06416644, source copy `cardio:ctgov-nct06416644-2025-08-26`, retrieved 2026-10-31)
- Started: 2023-04-01 (actual) (ClinicalTrials.gov record NCT06416644, source copy `cardio:ctgov-nct06416644-2025-08-26`, retrieved 2026-10-31)
- Primary completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT06416644, source copy `cardio:ctgov-nct06416644-2025-08-26`, retrieved 2026-10-31)
- Completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT06416644, source copy `cardio:ctgov-nct06416644-2025-08-26`, retrieved 2026-10-31)
- Countries: Portugal (ClinicalTrials.gov record NCT06416644, source copy `cardio:ctgov-nct06416644-2025-08-26`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06416644-2025-08-26`, retrieved 2026-10-31)

## The registry's words

- Brief title: The PORTuguese Registry of Supera Supported Femoral-Fopliteal Revascularization (SupPORT Registry)
- Acronym: SupPORT regist
- Condition: Lower Limb Ischemia
- Condition: Peripheral Arterial Disease
- Condition: Chronic Limb-Threatening Ischemia
- Condition: Chronic Limb Ischemia
- Condition: Atherosclerosis of Femoral Artery
- Condition: Superficial Femoral Artery Stenosis
- Condition: Superficial Femoral Artery Occlusion
- Condition: Superficial Femoral Artery Disease
- Condition: Superficial Femoral Artery Lesions
- Condition: Popliteal Artery Occlusion
- Condition: Popliteal Artery Stenosis
- Condition: Popliteal Arterial Stenosis
- Intervention (Device): Supera Vasculomimetic Stent
- Lead sponsor: Hospital do Divino Espírito Santo de Ponta Delgada
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)

## Provenance

Content hash: a434da1d606ebfa983aeac1fa5383f9c220d6378153e552f8f5fae904ae515c2
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
